Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Pfizer, inc. crawled time : 12:00 save search
Pfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO® in Adults Aged 18 to 59 at Increased Risk for RSV Disease
Published: 2024-04-09 (Crawled : 12:00) - biospace.com/
PFE | News A | $26.24 -0.08% 11M
|
Health Technology
|
| O: 0.73%
H: 2.49%
C: 0.11%
abrysvo disease positive risk for rsv results study
Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor for its Enobosarm Program for High Quality Weight Loss
Published: 2024-03-12 (Crawled : 12:00) - globenewswire.com
PFE | News A | $26.24 -0.08% 11M
|
Health Technology
|
| O: -0.21%
H: 0.11%
C: -1.06%
LLY | News | $741.37 1.37% 800K
|
Health Technology
|
| O: 0.9%
H: 2.03%
C: 1.89%
VERU | $1.415 11.42% 1.4M
|
Health Technology
|
| O: -0.53%
H: 2.22%
C: -3.59%
ALT | $7.72 3.35% 1.8M
|
Commercial Services
|
| O: 0.3%
H: 11.41%
C: 9.8%
medical program
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors
Published: 2024-03-07 (Crawled : 12:00) - prnewswire.com
PFE | News A | $26.24 -0.08% 11M
|
Health Technology
|
| O: 0.04%
H: 0.44%
C: -1.51%
NVS | News | $97.31 2.3% 2.3M
|
Health Technology
|
| O: -2.08%
H: 0.13%
C: -0.57%
BMY | $49.2 0.12% 2.9M
|
Health Technology
|
| O: 0.36%
H: 0.34%
C: -0.54%
XFOR | $1.335 -1.84% 1.2M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: -4.98%
EYPT | News | $18.025 6.34% 370K
|
Health Technology
|
| O: 2.56%
H: 1.37%
C: -4.13%
AQST | $4.315 -1.48% 1M
|
Health Technology
|
| O: 1.79%
H: 12.3%
C: 10.94%
ALKS | $24.49 1.75% 490K
|
Health Technology
|
| O: 1.11%
H: 0.96%
C: 0.65%
Arvinas Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-02-27 (Crawled : 12:00) - globenewswire.com
PFE | News A | $26.24 -0.08% 11M
|
Health Technology
|
| O: -0.22%
H: 0.29%
C: -0.85%
ARVN | $34.83 -0.2% 170K
|
Health Technology
|
| O: 0.0%
H: 1.25%
C: -1.6%
year update financial results
Arvinas and Pfizer’s Vepdegestrant (ARV-471) Receives FDA Fast Track Designation for the Treatment of Patients with ER+/HER2- Metastatic Breast Cancer
Published: 2024-02-06 (Crawled : 12:00) - globenewswire.com
PFE | News A | $26.24 -0.08% 11M
|
Health Technology
|
| O: 0.34%
H: 3.99%
C: 3.15%
ARVN | $34.83 -0.2% 170K
|
Health Technology
|
| O: 0.91%
H: 5.05%
C: 4.9%
arv-471 fda breast cancer treatment designation
Tisotumab Vedotin Marketing Authorization Application Validated by European Medicines Agency for Treatment of Recurrent or Metastatic Cervical Cancer
Published: 2024-02-02 (Crawled : 12:00) - globenewswire.com
GNMSF | News | $289.67 5.3K
|
Health Technology
|
| O: -0.78%
H: 0.3%
C: -0.84%
PFE | News A | $26.24 -0.08% 11M
|
Health Technology
|
| O: -0.4%
H: 0.07%
C: -0.92%
GMAB | News | $28.885 -0.29% 190K
|
Health Technology
|
| O: -1.21%
H: 0.72%
C: -0.11%
authorization cancer treatment application
Enthera Pharmaceuticals Appoints Lisa M. Olson as CEO and Announces Clinical Trial Progress with Ent001
Published: 2024-01-23 (Crawled : 12:00) - biospace.com/
PFE | News A | $26.24 -0.08% 11M
|
Health Technology
|
| O: 0.46%
H: 0.74%
C: -0.04%
ABT | News | $108.01 0.88% 1.2M
|
Health Technology
|
| O: -0.07%
H: 0.0%
C: 0.0%
ceo pharmaceuticals trial
TIVDAK® (tisotumab vedotin-tftv) Supplemental Biologics License Application Accepted for Priority Review by U.S. Food and Drug Administration for Patients with Recurrent or Metastatic Cervical Cancer
Published: 2024-01-09 (Crawled : 12:00) - globenewswire.com
GNMSF | News | $289.67 5.3K
|
Health Technology
|
| O: -3.69%
H: 1.71%
C: -2.41%
PFE | News A | $26.24 -0.08% 11M
|
Health Technology
|
| O: 0.07%
H: 0.88%
C: -0.68%
GMAB | News | $28.885 -0.29% 190K
|
Health Technology
|
| O: -1.1%
H: 0.46%
C: -0.06%
tivdak drug license review food cancer application
BioNTech Outlines 2024 Strategic Priorities at the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-09 (Crawled : 12:00) - globenewswire.com
PFE | News A | $26.24 -0.08% 11M
|
Health Technology
|
| O: 0.07%
H: 0.88%
C: -0.68%
BNTX | News | $88.24 0.26% 180K
|
Health Technology
|
| O: -2.48%
H: 0.82%
C: -0.37%
conference
Arvinas Announces Oversubscribed $350 Million Private Placement
Published: 2023-11-27 (Crawled : 12:00) - globenewswire.com
PFE | News A | $26.24 -0.08% 11M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: -1.98%
ARVN | $34.83 -0.2% 170K
|
Health Technology
|
| O: 2.51%
H: 11.93%
C: 7.54%
Arvinas Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-11-07 (Crawled : 12:00) - globenewswire.com
PFE | News A | $26.24 -0.08% 11M
|
Health Technology
|
| O: -0.32%
H: 0.98%
C: 0.55%
ARVN | $34.83 -0.2% 170K
|
Health Technology
|
| O: 1.0%
H: 4.2%
C: 4.04%
update financial results
BioNTech Announces Third Quarter 2023 Financial Results and Corporate Update
Published: 2023-11-06 (Crawled : 12:00) - globenewswire.com
GNMSF | News | $289.67 5.3K
|
Health Technology
|
| O: 0.24%
H: 3.29%
C: -1.11%
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
PFE | News A | $26.24 -0.08% 11M
|
Health Technology
|
| O: 0.19%
H: 0.29%
C: -0.45%
SNY | News | $47.5 0.74% 450K
|
Health Technology
|
| O: 0.21%
H: 0.0%
C: 0.0%
GMAB | News | $28.885 -0.29% 190K
|
Health Technology
|
| O: 0.55%
H: 0.44%
C: -1.37%
BNTX | News | $88.24 0.26% 180K
|
Health Technology
|
| O: 5.74%
H: 3.18%
C: -1.55%
update financial results
Pfizer Reports Third-Quarter 2023 Results
Published: 2023-10-31 (Crawled : 12:00) - biospace.com/
HLNCF | $4.13 5.4K
|
n/a
|
| O: 2.0%
H: 0.5%
C: 0.5%
HLN | $8.415 0.66% 1.8M
|
n/a
|
| O: 0.75%
H: 0.74%
C: 0.12%
AZNCF | News | $138.73 3.7K
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: -1.7%
PFE | News A | $26.24 -0.08% 11M
|
Health Technology
|
| O: -0.87%
H: 1.77%
C: 0.91%
BNTX | News | $88.24 0.26% 180K
|
Health Technology
|
| O: -1.65%
H: 2.78%
C: 2.0%
AZN | News | $70.87 1.06% 3M
|
Health Technology
|
| O: 0.08%
H: 0.41%
C: 0.38%
results
CRISPR Therapeutics Proposes New Appointment to the Board of Directors
Published: 2023-10-16 (Crawled : 12:00) - globenewswire.com
PFE | News A | $26.24 -0.08% 11M
|
Health Technology
|
| O: 2.24%
H: 3.32%
C: 1.34%
SRPT | $119.28 1.98% 88K
|
Health Technology
|
| O: -0.18%
H: 1.11%
C: -0.17%
CRSP | News M | $56.815 2.08% 680K
|
Health Technology
|
| O: 0.0%
H: 1.67%
C: 1.13%
crispr therapeutics
U.S. FDA Approves Pfizer’s BRAFTOVI® + MEKTOVI® for BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer
Published: 2023-10-12 (Crawled : 12:00) - biospace.com/
PFE | News A | $26.24 -0.08% 11M
|
Health Technology
|
| O: 0.0%
H: 0.33%
C: -0.57%
braftovi fda lung cancer cell
FDA Grants Priority Review for XTANDI® in Non-Metastatic Castration-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence
Published: 2023-08-23 (Crawled : 12:00) - biospace.com/
ALPMY | News | $9.53 690K
|
Manufacturing
|
| O: 0.59%
H: 0.46%
C: 0.46%
PFE | News A | $26.24 -0.08% 11M
|
Health Technology
|
| O: 0.68%
H: 0.11%
C: -1.16%
xtandi fda review cancer grants
Pfizer Reports Second-Quarter 2023 Results
Published: 2023-08-01 (Crawled : 12:00) - biospace.com/
TMO | News | $574.855 4.83% 1.1M
|
Health Technology
|
| O: -1.8%
H: 0.0%
C: 0.0%
PFE | News A | $26.24 -0.08% 11M
|
Health Technology
|
| O: -0.48%
H: 0.0%
C: 0.0%
BNTX | News | $88.24 0.26% 180K
|
Health Technology
|
| O: 1.14%
H: 0.0%
C: -1.36%
results
Caribou Biosciences Announces $25 Million Equity Investment from Pfizer
Published: 2023-07-06 (Crawled : 12:00) - globenewswire.com
CRBU | $4.055 1.63% 480K
|
Health Technology
|
| O: 37.25%
H: 22.86%
C: 6.07%
PFE | News A | $26.24 -0.08% 11M
|
Health Technology
|
| O: -0.71%
H: 0.19%
C: -1.57%
FDA Accepts Pfizer’s Application for Hemophilia B Gene Therapy Fidanacogene Elaparvovec
Published: 2023-06-27 (Crawled : 12:00) - biospace.com/
PFE | News A | $26.24 -0.08% 11M
|
Health Technology
|
| O: 0.19%
H: 0.11%
C: -1.46%
fda application therapy
Pfizer Provides Update on GLP-1-RA Clinical Development Program for Adults with Obesity and Type 2 Diabetes Mellitus
Published: 2023-06-26 (Crawled : 12:00) - biospace.com/
PFE | News A | $26.24 -0.08% 11M
|
Health Technology
|
| O: -3.36%
H: 0.09%
C: -0.34%
obesity update program diabetes
Gainers vs Losers
| 87% | 13% |
Top 10 Gainers
MTTR | News M | $4.64 166.67% 18M
|
AGBA | $2.61 108.8% 41M
|
Finance
CZOO | $9.32 86.77% 18M
|
EDBL | News | $6.7 78.19% 1.7M
|
OPRT | News | $3.37 49.78% 8.9M
|
Finance
MTC | $2.14 37.18% 4.9M
|
Technology Services
VNRX | $0.8 33.33% 2.9M
|
Health Technology
MLEC | $1.79 27.86% 2.6M
|
n/a
PALI | $6.29 27.59% 22M
|
Manufacturing
MCRB | $0.7902 26.51% 6.9M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.